Detalles de la búsqueda
1.
Dry and liquid formulations of IBT-V02, a novel multi-component toxoid vaccine, are effective against Staphylococcus aureus isolates from low-to-middle income countries.
Front Immunol;
15: 1373367, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38633244
2.
Evidence of Neutralizing and Non-Neutralizing Anti-Glucosaminidase Antibodies in Patients With S. Aureus Osteomyelitis and Their Association With Clinical Outcome Following Surgery in a Clinical Pilot.
Front Cell Infect Microbiol;
12: 876898, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35923804
3.
Antigenic landscapes on Staphylococcus aureus pore-forming toxins reveal insights into specificity and cross-neutralization.
MAbs;
14(1): 2083467, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35730685
4.
Hyperimmune Targeting Staphylococcal Toxins Effectively Protect Against USA 300 MRSA Infection in Mouse Bacteremia and Pneumonia Models.
Front Immunol;
13: 893921, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35655774
5.
Rational Design of Toxoid Vaccine Candidates for Staphylococcus aureus Leukocidin AB (LukAB).
Toxins (Basel);
11(6)2019 06 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-31207937
6.
A Critical Role for HlgA in Staphylococcus aureus Pathogenesis Revealed by A Switch in the SaeRS Two-Component Regulatory System.
Toxins (Basel);
10(9)2018 09 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-30231498
7.
Correction: Antibodies to S. aureus LukS-PV Attenuated Subunit Vaccine Neutralize a Broad Spectrum of Canonical and Non-Canonical Bicomponent Leukotoxin Pairs.
PLoS One;
10(11): e0143493, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26571027
8.
Antibodies to S. aureus LukS-PV Attenuated Subunit Vaccine Neutralize a Broad Spectrum of Canonical and Non-Canonical Bicomponent Leukotoxin Pairs.
PLoS One;
10(9): e0137874, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26367030
Resultados
1 -
8
de 8
1
Próxima >
>>